RESUMEN
Bacterial bronchial asthma provokes development of secondary immunodeficiency. In addition to conventional treatment 90 asthmatics were given standard doses of timogen and myelopid alone and in combination. Routine clinical and immunological tests show that the above medication corrects immunodeficiency and advances the efficacy of the basic treatment. In combination, timogen and myelopid displayed the highest efficacy.
Asunto(s)
Antiarrítmicos/administración & dosificación , Mexiletine/administración & dosificación , Complejos Prematuros Ventriculares/tratamiento farmacológico , Adolescente , Adulto , Anciano , Enfermedad Crónica , Preparaciones de Acción Retardada , Electrocardiografía , Electrocardiografía Ambulatoria , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Tiempo , Complejos Prematuros Ventriculares/diagnósticoAsunto(s)
Isquemia Miocárdica/tratamiento farmacológico , Inhibidores de Agregación Plaquetaria/uso terapéutico , Plaquetas/fisiología , Contraindicaciones , Educación Médica Continua , Hemostasis , Humanos , Infarto del Miocardio/etiología , Infarto del Miocardio/prevención & control , Isquemia Miocárdica/sangre , Isquemia Miocárdica/complicaciones , Inhibidores de Agregación Plaquetaria/clasificación , Federación de RusiaRESUMEN
The examination of 50 patients with acute myocardial infarction indicated that enhanced platelet functional activity was a prognostically unfavourable sign and associated with a higher risk for myocardial infarction complications. The application of aspirin, 250 mg daily, in patients with high platelet functional activity in the acute period of the disease failed to produce a beneficial antiaggregatory effect.
Asunto(s)
Aspirina/administración & dosificación , Infarto del Miocardio/sangre , Activación Plaquetaria/efectos de los fármacos , Agregación Plaquetaria/efectos de los fármacos , Administración Oral , Humanos , Activación Plaquetaria/fisiología , Agregación Plaquetaria/fisiología , Factores de TiempoRESUMEN
Patients with myocardial infarction in the presence of first angina pectoris have been found to display less platelet aggregability in the acute period of the disease than those with recurrent myocardial infarction, which is associated with a lower incidence of postinfarction complications and smaller plasma triglyceride levels. The changes observed in plasma lipid concentrations and platelet aggregation in different periods of the disease have been shown to be similar to those seen in patients with myocardial infarction concurrent with sustained angina.
Asunto(s)
Lípidos/sangre , Infarto del Miocardio/sangre , Agregación Plaquetaria , Angina de Pecho/complicaciones , Plaquetas/química , Colesterol/sangre , Humanos , Lipoproteínas HDL/sangre , Masculino , Persona de Mediana Edad , Infarto del Miocardio/etiología , Triglicéridos/sangreRESUMEN
A study of the effect of essentiale-forte in myocardial infarction patients demonstrated favorable shifts in plasma lipid spectrum and ADF-induced platelet aggregation.